Maven Securities LTD Iovance Biotherapeutics, Inc. Transaction History

Maven Securities LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $1.22 Million - $1.6 Million	-60,046 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $48,108 - $97,424	2,946 Added 5.16%	60,046 $1.66 Million
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $1.64 Million - $3 Million	57,100 New	57,100 $1.79 Million
Q4 2020 Feb 12, 2021	SELL	$28.04 - $50.26 $6.73 Million - $12.1 Million	-240,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$27.75 - $36.3 $6.66 Million - $8.71 Million	240,000 New	240,000 $7.88 Million

305

221M

3.05M

1.6M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.15B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.